WEISS MICHAEL S 4
4 · TG THERAPEUTICS, INC. · Filed Jan 30, 2025
Insider Transaction Report
Form 4
WEISS MICHAEL S
DirectorCEO
Transactions
- Award
Common Stock
2025-01-29+750,000→ 13,824,929 total
Footnotes (2)
- [F1]Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period.
- [F2]Includes shares of restricted Common Stock, which vest over various time periods.